| Year |
Citation |
Score |
| 2019 |
Allan R, Haughie S, Ahrens R, Singh S, Ward J. A Dose-Response Study Examining the Use of Methacholine Challenge to Demonstrate Local Therapeutic Equivalence of the Salmeterol Component of Generic Inhaled Fluticasone Propionate/Salmeterol Combination Products. Journal of Aerosol Medicine and Pulmonary Drug Delivery. PMID 31259673 DOI: 10.1089/Jamp.2018.1519 |
0.38 |
|
| 2015 |
Konstan MW, Plant BJ, Elborn JS, Rodriguez S, Munck A, Ahrens R, Johnson C. Efficacy response in CF patients treated with ivacaftor: post-hoc analysis. Pediatric Pulmonology. 50: 447-55. PMID 25755212 DOI: 10.1002/Ppul.23173 |
0.319 |
|
| 2014 |
Mondal P, Kandala B, Ahrens R, Chesrown SE, Hendeles L. Nonprescription racemic epinephrine for asthma. The Journal of Allergy and Clinical Immunology. in Practice. 2: 575-8. PMID 25213051 DOI: 10.1016/J.Jaip.2014.02.014 |
0.343 |
|
| 2011 |
Prabhakaran S, Shuster J, Ahrens R, Hendeles L. Methacholine challenge as a clinical bioassay of pulmonary delivery of a long-acting β₂-adrenergic agonist. Pharmacotherapy. 31: 449-57. PMID 21923426 DOI: 10.1592/Phco.31.5.449 |
0.308 |
|
| 2010 |
Konstan MW, Liou TG, Strausbaugh SD, Ahrens R, Kanga JF, Graff GR, Moffett K, Millard SL, Nasr SZ, Siméon E, Spénard J, Grondin J. Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic Fibrosis. Gastroenterology Research and Practice. 2010: 898193. PMID 21197074 DOI: 10.1155/2010/898193 |
0.309 |
|
| 2006 |
Gibson RL, Retsch-Bogart GZ, Oermann C, Milla C, Pilewski J, Daines C, Ahrens R, Leon K, Cohen M, McNamara S, Callahan TL, Markus R, Burns JL. Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis. Pediatric Pulmonology. 41: 656-65. PMID 16703579 DOI: 10.1002/Ppul.20429 |
0.322 |
|
| 2005 |
Hendeles L, Marshik PL, Ahrens R, Kifle Y, Shuster J. Response to nonprescription epinephrine inhaler during nocturnal asthma. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 95: 530-4. PMID 16400891 DOI: 10.1016/S1081-1206(10)61014-9 |
0.328 |
|
| 2005 |
Moss RB, Mayer-Hamblett N, Wagener J, Daines C, Hale K, Ahrens R, Gibson RL, Anderson P, Retsch-Bogart G, Nasr SZ, Noth I, Waltz D, Zeitlin P, Ramsey B, Starko K. Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease. Pediatric Pulmonology. 39: 209-18. PMID 15573395 DOI: 10.1002/Ppul.20152 |
0.339 |
|
| 2004 |
Hendeles L, Beaty R, Ahrens R, Stevens G, Harman EM. Response to inhaled albuterol during nocturnal asthma. The Journal of Allergy and Clinical Immunology. 113: 1058-62. PMID 15208585 DOI: 10.1016/J.Jaci.2004.03.046 |
0.361 |
|
| 1999 |
Geoffroy P, Lalonde RL, Ahrens R, Clarke W, Hill MR, Vaughan LM, Grossman J. Clinical comparability of albuterol delivered by the breath-actuated inhaler (Spiros) and albuterol by MDI in patients with asthma. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 82: 377-82. PMID 10227336 DOI: 10.1016/S1081-1206(10)63287-5 |
0.377 |
|
| 1996 |
Marshik PL, Thomas D, Ahrens R, Braver H, Hendeles L. 534 Dose-response of inhaled beclomethasone (B) for attenuating the airway responses to allergen The Journal of Allergy and Clinical Immunology. 97: 316-316. DOI: 10.1016/S0091-6749(96)80752-4 |
0.324 |
|
| 1995 |
Balough K, McCubbin M, Weinberger M, Smits W, Ahrens R, Fick R. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatric Pulmonology. 20: 63-70. PMID 8570304 DOI: 10.1002/Ppul.1950200203 |
0.317 |
|
| 1995 |
McCubbin MM, Milavetz G, Grandgeorge S, Weinberger M, Ahrens R, Sargent C, Vaughan LM. A bioassay for topical and systemic effect of three inhaled corticosteroids. Clinical Pharmacology and Therapeutics. 57: 455-60. PMID 7712675 DOI: 10.1016/0009-9236(95)90216-3 |
0.343 |
|
| 1995 |
Ahrens R, Lux C, Bahl T, Han SH. Choosing the metered-dose inhaler spacer or holding chamber that matches the patient's need: evidence that the specific drug being delivered is an important consideration. The Journal of Allergy and Clinical Immunology. 96: 288-94. PMID 7636073 DOI: 10.1016/S0091-6749(95)70208-3 |
0.338 |
|
| 1988 |
Massey KL, Hill M, Harman E, Rutledge DR, Ahrens R, Hendeles L. Dose response of inhaled gallopamil (D600), a calcium channel blocker, in attenuating airway reactivity to methacholine and exercise. The Journal of Allergy and Clinical Immunology. 81: 912-8. PMID 3286722 DOI: 10.1016/0091-6749(88)90950-5 |
0.313 |
|
| 1985 |
Ahrens R, Harris J, Annis L, Milavetz G. 225 Effect of metaproterenol (M) and albuterol (AL) administered by metered dose inhaler (MDI) on non-specific airway responsiveness (NR) The Journal of Allergy and Clinical Immunology. 75: 161. DOI: 10.1016/0091-6749(85)90360-4 |
0.319 |
|
| 1981 |
Weinberger M, Hendeles L, Ahrens R. Clinical pharmacology of drugs used for asthma. Pediatric Clinics of North America. 28: 47-75. PMID 6782542 DOI: 10.1016/S0031-3955(16)33962-1 |
0.305 |
|
| Show low-probability matches. |